1. Home
  2. PASG vs HHS Comparison

PASG vs HHS Comparison

Compare PASG & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASG
  • HHS
  • Stock Information
  • Founded
  • PASG 2017
  • HHS 1923
  • Country
  • PASG United States
  • HHS United States
  • Employees
  • PASG N/A
  • HHS N/A
  • Industry
  • PASG Biotechnology: Pharmaceutical Preparations
  • HHS Advertising
  • Sector
  • PASG Health Care
  • HHS Consumer Discretionary
  • Exchange
  • PASG Nasdaq
  • HHS Nasdaq
  • Market Cap
  • PASG 31.1M
  • HHS 37.0M
  • IPO Year
  • PASG 2020
  • HHS N/A
  • Fundamental
  • Price
  • PASG $0.45
  • HHS $4.44
  • Analyst Decision
  • PASG Strong Buy
  • HHS
  • Analyst Count
  • PASG 3
  • HHS 0
  • Target Price
  • PASG $7.67
  • HHS N/A
  • AVG Volume (30 Days)
  • PASG 387.0K
  • HHS 8.2K
  • Earning Date
  • PASG 05-13-2025
  • HHS 05-14-2025
  • Dividend Yield
  • PASG N/A
  • HHS N/A
  • EPS Growth
  • PASG N/A
  • HHS N/A
  • EPS
  • PASG N/A
  • HHS N/A
  • Revenue
  • PASG N/A
  • HHS $181,355,000.00
  • Revenue This Year
  • PASG N/A
  • HHS $6.54
  • Revenue Next Year
  • PASG N/A
  • HHS N/A
  • P/E Ratio
  • PASG N/A
  • HHS N/A
  • Revenue Growth
  • PASG N/A
  • HHS N/A
  • 52 Week Low
  • PASG $0.26
  • HHS $4.20
  • 52 Week High
  • PASG $1.33
  • HHS $8.87
  • Technical
  • Relative Strength Index (RSI)
  • PASG 60.67
  • HHS 45.10
  • Support Level
  • PASG $0.40
  • HHS $4.20
  • Resistance Level
  • PASG $0.52
  • HHS $5.00
  • Average True Range (ATR)
  • PASG 0.05
  • HHS 0.29
  • MACD
  • PASG 0.02
  • HHS -0.03
  • Stochastic Oscillator
  • PASG 71.19
  • HHS 30.00

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: